FosamaxMDL1789-Calendar Posted: February 9, 2024 In re Fosamax Products Liability Litigation, MDL No. 1789 MDL No. 1789 Court Calendar U.S. District Court calendar related to all pending cases in In re Fosamax Products Liability Litigation, MDL No. 1789 (S.D.N.Y.). View other court info: •· Fosamax Court Calendar •· Fosamax Court Orders •· Fosamax Court Forms •· Fosamax Pleadings & Filings •· Fosamax Trials •· Fosamax Remand Information Date Time Subject 10/07/06 Any case subject to a conditional transfer order on or prior to this date is eligible for inclusion in the early trial pool. 01/29/07 9:30am Status conference with Magistrate Judge Francis (subject: initial meeting with Magistrate) 11:30am Status conference with Judge Keenan (subject: trial selection process) 02/19/07 PPF’s due for all potential early trial cases. 04/13/07 PSC expert reports on class certification issues due. 05/11/07 Merck expert reports on class certification issues due. 05/21/07 Deadline to review potential early trial cases. Merck selects 12 (and sends to PSC via U.S. mail postmarked on this date), PSC selects 12 (and sends to Merck via U.S. mail postmarked on this date), Court selects 1. 06/01/07 Deposition of Dr. Robert Marx, Miami, Florida. 06/14/07 Deposition of Paul Mulholland, CPA. 06/14/07 Deposition of Dr. Alistair Goss, Melbourne, Australia. 07/12/07 Deposition of Merck’s expert, Jeri Nieves, Ph.D. 07/17/07 Deposition of Merck’s expert, John Bilezikian, M.D. 07/19/07 Deposition of Merck’s expert, Paul A. Bartlett, Ph.D. 07/20/07 Deadline to complete expert discovery on class certification issues. 07/30/07 Deposition of Merck’s expert, Robert Glickman, D.M.D. 08/10/07 PSC class certification brief due. 09/10/07 Merck class certification brief due (hearing to be set in September 2007). 11/30/07 Dental Monitoring Class Certification Hearing 03/28/08 Deposition of Anastasia Daifotis, V.P. of Clinical Research, Merck Research Labs, New York 04/09/08 Informational Meeting for MDL Plaintiffs’ Counsel, 3:00 p.m. PT, Alsace 2, Wynn Las Vegas Resort & Casino (limited solely to those counsel with plaintiffs’ cases pending in the Fosamax MDL). For additional information, email Jessica Bohon atjbohon@levinlaw.com or Tim O’Brien tobrien@levinlaw.com 05/07/08 Deposition of Art Santora, Executive Director, Clinical Research, Merck Research Labs, New York 05/20/08 2nd Day of Depo. of Art Santora, Executive Director, Clinical Research, Merck Research Labs, New York 05/29/08 Deposition of Donald B. Kimmel, D.D.S., Ph.D., Director, Molecular Endocrinology, Merck Research Labs, Warrington, PA 06/02/08 10:00 a.m., Hearing on PSC Motion to Compel, Judge Keenan 07/25/08 9:30am Discovery status conference with Magistrate Judge Francis, Courtroom 18D 08/28/08 Deposition of Michelle Flicker, M.D., Ph.D., Director, Regulatory Affairs, Merck & Co., New York 09/24/08 Deposition of Dr. Michael Goldberg, former Senior Director of Worldwide Product Safety & Epidemiology., Philadelphia 09/26/08 9:00am Discovery Status Conference with Magistrate Judge Francis 10/01/08 Case-specific fact discovery deadline for the 25 early trial eligible cases. Thereafter, PSC selects 1, Merck selects 1, and Court selects 1, for early trial. 10/16/08 10:30am Courtroom 20C Case Management Conference with District Court to address proposed CMOs relating to schedule to complete all generic expert discovery in this MDL and for summary judgment motions 11/12/08 Discovery Status Conference with Magistrate Judge Francis, 9:30 a.m. 12/04/08 2nd day of Deposition of Dr. Michael Goldberg, former Senior Director of Worldwide Product Safety & Epidemiology, San Francisco POSTPONED Deposition of Bruce Psaty, M.D., Ph.D 01/16/09 Discovery Status Conference with Magistrate Judge Francis 01/22/09 Deposition of Ron Rogers, Merck Spokesman., New York 01/23/09 Plaintiff’s Rule 26(a)(2) Expert Disclosures Due 01/30/09 Deposition of Georgianna Harris, Ph.D., Director, Regulatory Affairs, Merck & Co., New York 02/09/09 Deposition of Christiane Arsever, M.D., Associate Director, Medical Services, Merck & Co., Philadelphia 02/13/09 Deposition of Ms. Ellen Westrick, Executive Director, Office of Medical/Legal, Merck & Co., Naples, FL 02/16/09 Deposition of Alfred Reszka, Ph.D., Researcher, Department of Molecular Endocrinology and Bone Biology, Merck Research Labs., Philadelphia 02/19/09 Deposition of Peter Gruer, M.D., former Director, Worldwide Product Safety & Epidemiology., Philadelphia 02/19/09 Deposition of Dr. Frank Seebach, Director, Regulatory Affairs, Merck & Co., New York 02/20/09 Defendant’s Rule 26(a)(2) Expert Disclosures Due 02/24/09 Deposition of Philip Ross, M.D., Senior Director and Acting Head, Medical Communications Department, Merck & Co., New York 02/26/09 Deposition of Anne DePapp, Executive Scientific Director, Merck Human Health Division, Philadelphia 02/26/09 Deposition of Patrick Counihan, Vice President of Health Care Systems, Merck & Co., Philadelphia 03/04/09 Deposition of Jack Gotcher, DMD, Ph.D., Knoxville, TN 03/04/09 Deposition of Daniel Baran, M.D., Senior Medical Director, Merck & Co., Philadelphia 03/05/09 Deposition of Patrick Magri, Vice President of Marketing, Merck & Co., Philadelphia 03/05/09 Deposition of Ms. Linda Hostelley, Vice President Worldwide Product Safety & Quality Assurance, Merck & Co., Philadelphia 03/09/09 Deposition of Dr. Gordon Guyatt, Hamilton, Ontario 03/12/09 Deposition of Suzanne Parisian, M.D., Phoenix, Arizona 03/16/09 Deposition of Curt D. Furberg, M.D., Washington, D.C. 03/17/09 Deposition of Mahyar Etminan, Pharm.D., M.Sc. (epidemiology), Vancouver, British Columbia 03/20/09 Discovery Status Conference with Magistrate Judge Francis, 2 p.m. 03/23/09 Deposition of Mary Ellen Fiore, CRMSS Associate, Merck & Co., Philadelphia 03/24/09 Discovery deposition of Alastair Goss, DDSc, Adelaide, Australia. 03/25/09 Deposition of John Hellstein, DDS, M.Sc., Iowa City, IA 03/25/09 Deposition of Nancy Santanello, MD, MS, Executive Director, Department of Epidemiology, Merck Research Labs, Philadelphia 03/26/09 Trial deposition of Alastair Goss, DDSc, Adelaide, Australia. 03/26/09 Deposition of Christine Peverly, Clinical Research, Merck Research Labs, New York City 03/27/09 Deposition of Robert Marx, DDS, Miami, FL 03/31/09 Deposition of Thomas Bold MD, Senior Director, Clinical Risk Management and Safety Surveillance, Merck Research Labs, Philadelphia 03/31/09 Deadline to complete MDL non-class discovery. 03/31/09 Depositions of Plaintiff’s Experts Completed 04/03/09 Deposition of Scott Tomar, D.M.D., Ph.D., Gainesville, FL 04/10/09 Deposition of Jeri Nieves, Ph., New York City 04/13/09 Deposition of Robert Glickman, D.M.D., New York City 04/14/09 Deposition of Lisa Rarick, M.D., Washington, D.C. 04/15/09 Deposition of Ellen Eisenberg, D.M.D., Farmington, CT 04/17/09 Deposition of John Bilezikian, M.D., New York City 04/17/09 Deposition of Daniel Shames, M.D., Washington, D.C. 04/20/09 Deposition of Paul Barlett, Ph.D., Oakland, CA 04/22/09 Deposition of Michael McClung, M.D., Portland, OR (CANCELLED AS MERCK WITHDREW EXPERT) 04/24/09 Deposition of David Dempster, Ph.D., New York City 04/27/09 Deposition of James Adams, Associate Director, Worldwide Regulatory Affairs, Merck & Co., New York City. 04/28/09 Deposition of Elizabeth Holt, M.D., Ph.D., New York City 04/29/09 Deposition of Jane Cauley, Dr.PH, Pittsburgh, PA 04/30/09 Depositions of Defendant’s Experts Completed 05/08/09 Daubert Motions Due; Dispositive Motions Due 06/08/09 Daubert Opposition Briefs Due; Dispositive Motions Opposition Briefs Due 06/18/09 Daubert Reply Briefs Due; Dispositive Motions Reply Briefs Due 07/08/09 Boles v. Merck & Co.: Motions in Limine Due 07/9-10/09 Daubert hearing before Judge Keenan 07/15/09 Boles v. Merck & Co.: Deposition Designations Exchanged 07/16/09 11:00am Courtroom 20-C Summary judgment hearing in Shirley Boles v. Merck & Co., Inc. 07/20/09 Boles v. Merck & Co.: Exchange Portions of Pretrial Order (including exhibit and witness lists) 07/22/09 Boles v. Merck & Co.: Oppositions to Motions in Limine Due 07/28/09 Boles v. Merck & Co.: Joint Pretrial Order (including witness and exhibit lists) and Pretrial Memoranda Due 07/29/09 3:00 Courtroom 20-C Boles v. Merck & Co.: Oral Arguments on Motions in Limine 07/29/09 Boles v. Merck & Co.: Deposition Counter-Designations and Objections Exchanged 08/06/09 Boles v. Merck & Co.: Deposition Counter-Counter-Designations and Objections Exchanged 08/10/09 Boles v. Merck & Co.: Premarked Exhibits and Proposed Voir Dire Questions to be Delivered to the Court 08/11/09 Boles v. Merck & Co.: Proposed Requests to Charge to be Delivered to the Court 08/11/09 Trial 1: Shirley Boles v. Merck & Co. 01/11/10 11:00am Courtroom 20-C Summary judgment hearing in Maley trial case 02/01/10 11:00am Courtroom 20-C Status Conference with Judge Keenan re selection of 3rd early trial case 03/04/10 Louise Maley v. Merck & Co.: Motions in Limine Due 03/08/10 Louise Maley v. Merck & Co.: Exchange Deposition Page and Line Designations 03/18/10 Louise Maley v. Merck & Co.: Oppositions to Motions in Limine Due 03/25/10 Louise Maley v. Merck & Co.: Reply Briefs re Motions in Limine Due 03/29/10 Louise Maley v. Merck & Co.: Exchange deposition Page and Line Counter-Designations 04/05/10 Louise Maley v. Merck & Co.: Exchange Objections and Counter-counter-Designations 04/06/10 Louise Maley v. Merck & Co.: Pretrial Memoranda and Joint Pretrial Order Due 04/13/10 Parties to Notify Court if Hearing Needed on Objections to Depo Designations 04/18/10 Louise Maley v. Merck & Co.: Electronic Exhibits to Court 04/19/10 Louise Maley v. Merck & Co.: Proposed Voir Dire Questions and Proposed Requests to Charge Due 04/19/10 Trial 2: Louise Maley v. Merck & Co. 05/27/10 4:00 p.m. Motion in Limine Hearing 06/07/10 Retrial of Trial 1: Shirley Boles v. Merck & Co. 06/25/10 Graves v. Merck & Co.: Plaintiff’s Rule 26(a)(2) Disclosures Due 07/26/10 Graves v. Merck & Co.: Defendant’s Rule 26(a)(2) Disclosures Due 08/06/10 Graves v. Merck & Co.: Plaintiff’s Expert Depo Deadline 08/25/10 Graves v. Merck & Co.: Defendant’s Expert Depo Deadline 09/08/10 10:30a.m.Courtroom 20-C Oral Argument: Merck’s Motions for New Trial in Boles v. Merck & Co. 09/10/10 Daubert Motions and Motions for Summary Judgment Due 09/17/10 Motions in Limine Due 09/24/10 Oppositions to Daubert and Motions for Summary Judgment Due 10/01/10 Replies to Daubert and Motions for Summary Judgment Due Oppositions to Motions in Limine Due 10/04/10 Graves v. Merck & Co.: Deposition Designations Due 10/08/10 Relies to Motions in Limine Due 10/12/10 Daubert and MSJ Hearing – 3:30p.m. 10/15/10 Exchange Draft Pretrial Order 10/18/10 Depo Counter-Designations and Objections Due 10/22/10 Joint Pretrial Order Due to Court Pretrial Memoranda Due to Court 10/25/10 Depo Counter-counter Designations and Objections Due Proposed Voir Dire Questions to Court 10/29/10 Electronic Exhibits to Court 11/01/10 Draft Jury Instructions to Court Trial 11/01/10 Trial 3: Judith Graves v. Merck & Co. 09/07/11 Trial 4: Linda Secrest v. Merck & Co. Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A. 316 South Baylen Street Suite 600 Pensacola, FL 32502-5996ph: (850) 435-7000 • toll free: (888) 435-7001 • fax: (850) 435-7020 For more information contact Fosamax Attorney Tim O’Brien
Levin Law